(Q64129816)

English

Virologic outcomes of first-line HAART and associated factors among Chinese patients with HIV in three sentinel antiretroviral treatment sites

scientific article published on September 25, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Virologic outcomes of first-line HAART and associated factors among Chinese patients with HIV in three sentinel antiretroviral treatment sites (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Yuhua Ruan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Hui Xing

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Xia Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Heng Tang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Zhe Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Hongwei Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Bin Su

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jianjun Wu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Hanping Li

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Lingjie Liao

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jingyun Li

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Julia Wei Wu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Yiming Shao

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

0 references

publication date

25 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-3156.2010.02621.x

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20868414

19 July 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-3156.2010.02621.x

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3156.2010.02621.x/fullpdf

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Tropical Medicine and International Health

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1357-1363

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?

1

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

2

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

3

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

4

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania

5

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience

7

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad

8

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

9

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China

10

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy

11

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China

12

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CP

13

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Rationale and uses of a public HIV drug-resistance database

14

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

15

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection

16

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy

17

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

19

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China.

20

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Five-year outcomes of the China National Free Antiretroviral Treatment Program

22

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai

23

1 reference

10.1111/J.1365-3156.2010.02621.X

https://api.crossref.org/works/10.1111/J.1365-3156.2010.02621.X

19 July 2024

Identifiers

10.1111/J.1365-3156.2010.02621.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20868414%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64129816&oldid=2208218395"